Plasmidic qnrA3 enhances Escherichia coli fitness in absence of antibiotic exposure
- PMID: 21915350
- PMCID: PMC3168526
- DOI: 10.1371/journal.pone.0024552
Plasmidic qnrA3 enhances Escherichia coli fitness in absence of antibiotic exposure
Abstract
The widespread presence of plasmid-mediated quinolone resistance determinants, particularly qnr genes, has become a current issue. By protecting DNA-gyrase from quinolones, Qnr proteins confer a low level quinolone resistance that is not sufficient to explain their emergence. Since Qnr proteins were hypothesized to act as DNA-binding protein regulators, qnr genes could have emerged by providing a selective advantage other than antibiotic resistance. We investigated host fitness of Escherichia coli isogenic strains after acquisition of the qnrA3 gene, inserted either alone onto a small plasmid (pBR322), or harbored on a large conjugative native plasmid, pHe96(qnrA3) found in a clinical isolate. The isogenic strains were derived from the susceptible E. coli CFT073, a virulent B2 group strain known to infect bladder and kidneys in a mouse model of pyelonephritis. In vitro experiments included growth analysis by automatic spectrophotometry and flow cytometry, and competitions with CFU enumeration. In vivo experiments included infection with each strain and pairwise competitions in absence of antimicrobial exposure. As controls for our experiments we used mutations known to reduce fitness (rpsL K42N mutation) or to enhance fitness (tetA deletion in pBR322). E. coli CFT073 transformed with pBRAM(PBR322-qnrA3) had significantly higher maximal OD than E. coli CFT073 transformed with pBR322 or pBR322ΔtetA, and in vivo competitions were more often won by the qnrA3 carrying strain (24 victories vs. 9 loss among 42 competitions, p = 0.001). In contrast, when pHe96(qnrA3) was introduced by conjugation in E. coli CFT073, it exerted a fitness cost shown by an impaired growth observed in vitro and in vivo and a majority of lost competitions (33/35, p<0.0001). In conclusion, qnrA3 acquisition enhanced bacterial fitness, which may explain qnr emergence and suggests a regulation role of qnr. However, fitness was reduced when qnrA3 was inserted onto multidrug-resistant plasmids and this can slow down its dissemination without antibiotic exposure.
Conflict of interest statement
Figures
Similar articles
-
Diverse phenotypic and genotypic characterization among clinical Klebsiella pneumoniae and Escherichia coli isolates carrying plasmid-mediated quinolone resistance determinants.Microb Drug Resist. 2011 Sep;17(3):363-7. doi: 10.1089/mdr.2011.0034. Epub 2011 May 12. Microb Drug Resist. 2011. PMID: 21563956
-
Low selection of topoisomerase mutants from strains of Escherichia coli harbouring plasmid-borne qnr genes.J Antimicrob Chemother. 2008 May;61(5):1007-15. doi: 10.1093/jac/dkn077. Epub 2008 Mar 6. J Antimicrob Chemother. 2008. PMID: 18325893
-
Ciprofloxacin treatment failure in a murine model of pyelonephritis due to an AAC(6')-Ib-cr-producing Escherichia coli strain susceptible to ciprofloxacin in vitro.Antimicrob Agents Chemother. 2013 Dec;57(12):5830-5. doi: 10.1128/AAC.01489-13. Epub 2013 Sep 9. Antimicrob Agents Chemother. 2013. PMID: 24018262 Free PMC article.
-
Quinolone resistance in bacteria: emphasis on plasmid-mediated mechanisms.Int J Antimicrob Agents. 2005 Jun;25(6):453-63. doi: 10.1016/j.ijantimicag.2005.04.002. Int J Antimicrob Agents. 2005. PMID: 15890498 Review.
-
[Classification and prevalence of plasmid-mediated quinolone resistance qnr genes in China--A review].Wei Sheng Wu Xue Bao. 2016 Feb 4;56(2):169-79. Wei Sheng Wu Xue Bao. 2016. PMID: 27373065 Review. Chinese.
Cited by
-
Antifungal Exposure and Resistance Development: Defining Minimal Selective Antifungal Concentrations and Testing Methodologies.Front Fungal Biol. 2022 Jun 13;3:918717. doi: 10.3389/ffunb.2022.918717. eCollection 2022. Front Fungal Biol. 2022. PMID: 37746188 Free PMC article.
-
The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic.Front Public Health. 2022 Dec 21;10:1025633. doi: 10.3389/fpubh.2022.1025633. eCollection 2022. Front Public Health. 2022. PMID: 36620240 Free PMC article. Review.
-
Successful Host Adaptation of IncK2 Plasmids.Front Microbiol. 2019 Oct 15;10:2384. doi: 10.3389/fmicb.2019.02384. eCollection 2019. Front Microbiol. 2019. PMID: 31681238 Free PMC article.
-
Effects of In vivo Emergent Tigecycline Resistance on the Pathogenic Potential of Acinetobacter baumannii.Sci Rep. 2018 Mar 9;8(1):4234. doi: 10.1038/s41598-018-22549-6. Sci Rep. 2018. PMID: 29523824 Free PMC article.
-
Double-Serine Fluoroquinolone Resistance Mutations Advance Major International Clones and Lineages of Various Multi-Drug Resistant Bacteria.Front Microbiol. 2017 Nov 16;8:2261. doi: 10.3389/fmicb.2017.02261. eCollection 2017. Front Microbiol. 2017. PMID: 29250038 Free PMC article. Review.
References
-
- Hooper DC. Mechanisms of action and resistance of older and newer fluoroquinolones. Clin Infect Dis. 2000;31(Suppl 2):S24–28. - PubMed
-
- Heisig P. Type II topoisomerases–inhibitors, repair mechanisms and mutations. Mutagenesis. 2009;24:465–469. - PubMed
-
- Goossens H. Antibiotic consumption and link to resistance. Clin Microbiol Infect. 2009;15(Suppl 3):12–15. - PubMed
-
- Jacoby GA. Mechanisms of resistance to quinolones. Clin Infect Dis. 2005;41(Suppl 2):S120–126. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
